Stories about Route of administration

Subscribe to Route of administration

02.12.2020 – 13:00

BD (Becton, Dickinson and Company)
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years

Franklin Lakes, N.j. (ots/PRNewswire) - - Investment includes new manufacturing facility in Europe BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and ...

more
15.10.2020 – 11:27

Technische Universität München
Fighting corona with machine learning

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36254/ NEWS RELEASE The Bavarian Research Foundation is funding five TUM-research projects on Covid-19 Fighting corona with machine learning The Technical University of Munich (TUM) is starting five new research projects that focus on the ...

more
09.09.2020 – 07:00

UCB Pharma
Final Phase II Results for UCB's Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances

Brussels (ots/PRNewswire) - - Phase II data demonstrated clinically meaningful platelet count increases with meaningful decreases in IgG concentration - Rozanolixizumab's subcutaneous route of administration shows potential to deliver targeted individualized patient care for people living with Primary Immune ...

more
17.02.2020 – 10:00

Fresenius Kabi Deutschland GmbH
A new expert consensus publication provides practical guidance on the use of omega-3 fatty acids in parenteral nutrition

Bad Homburg (ots) - Fresenius Kabi, a global leader in clinical nutrition, announces that the Journal of Parenteral and Enteral Nutrition (JPEN) has recently published "Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice".(1) The publication represents the largest set of expert consensus ...

more
10.12.2019 – 01:45

UCB Pharma
UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting

Brussels (ots/PRNewswire) - - Phase II data demonstrate that rozanolixizumab was well tolerated by patients with primary ITP across all dose groups - Clinically relevant improvements in platelet count and decrease in immunoglobin G (IgG) levels were observed in all dose groups - Safety, tolerability and efficacy ...

more
06.12.2019 – 03:00

Fresenius Kabi Deutschland GmbH

2
Medical experts highlight nutrition survey data during 20th PENSA Congress 2019 in Hong Kong

more
14.02.2019 – 07:30

Gerresheimer AG
Gerresheimer back on growth path and sets course for the future

Duesseldorf (ots) - - Revenues at constant exchange rates up 4.3% in the financial year 2018 to EUR 1,406.7m - Adjusted EBITDA at constant exchange rates at EUR 307.5m, excluding the Advanced Technologies Division and other one-off effects, and despite substantially negative energy costs and resin prices - Strong adjusted net income after non-controlling ...
One document
more
01.02.2019 – 11:02

Brenntag AG
Brenntag UK and Ireland announces the distribution of 3M Glass Bubbles and Boron Nitride fillers into the polymers and rubber sectors

Dear all, Please find attached a press release regarding the announcement of Brenntag UK and Ireland on the distribution of 3M Glass Bubbles and Boron Nitride fillers into the polymers and rubber sectors. For further ...
Website Brenntag UK and Ireland

more
11.10.2018 – 07:46

Gerresheimer AG
Andreas Schütte steps down from Management Board of Gerresheimer AG

Düsseldorf (ots) - Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in order to pursue new career challenges. The Supervisory Board of Gerresheimer AG approved this wish at its meeting yesterday. Andreas Schütte has served on ...
One document
more

1